baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Discount Zert PFE .../ DE000ME5FNW4 /

31/05/2024 18:59:29	Chg.+0.05	Bid22:00:34	Ask22:00:34	Underlying	Strike price	Expiration date	Option type
20.01EUR	+0.25%	- Bid Size: -	- Ask Size: -	Pfizer Inc	- USD	27/06/2025	Call

GlobeNewswire 31/05 Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine

GlobeNewswire 16/05 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...

TeleTrader 01/05 Pfizer's Q1 revenue drops 20% to $14.9 billion

GlobeNewswire 30/04 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...

GlobeNewswire 22/03 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...

GlobeNewswire 20/03 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 07/03 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 07/03 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 05/03 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...

GlobeNewswire 28/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 28/02 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 27/02 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...

GlobeNewswire 23/02 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

GlobeNewswire 20/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 16/02 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...

GlobeNewswire 11/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 08/02 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...

GlobeNewswire 06/02 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...

GlobeNewswire 03/02 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

TeleTrader 30/01 Pfizer posts Q4 revenue of $14B, reaffirms guidance

GlobeNewswire 26/01 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...

GlobeNewswire 26/01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 18/01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 19/12/2023 Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, N...

Morgan Stanley Discount Zert PFE .../ DE000ME5FNW4 /

If you wish to receive reply to your feedback, please provide your email address.